Gilead Sciences Inc (NASDAQ:GILD)
| 60.80 Delayed Data As of Oct 23 |  +0.13 / +0.21%Today’s Change | 59.65 Today|||52-Week Range 85.97 | -6.43% Year-to-Date |
Latest GILD News | Press Releases
| Where Things Stand in the Coronavirus Vaccine Race 10:15am / MotleyFool.com - Paid Partner Content | Why Gilead Sciences Stock Is on the Move Today Oct 23 / MotleyFool.com - Paid Partner Content |
| 2 Coronavirus Stocks to Avoid This Month 6:30am / MotleyFool.com - Paid Partner Content | Will Coronavirus Woes Affect Gilead's (GILD) Q3 Earnings? Oct 23 / Zacks.com - Paid Partner Content |
| US Indexes Close Flat Friday Oct 23 / GuruFocus News - Paid Partner Content | Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus Oct 22 / MotleyFool.com - Paid Partner Content |
| Werner, Carlisle, Gilead, Intel and Mattel as Zacks Bull and Bear of the Day Oct 23 / Zacks.com - Paid Partner Content | Stimulus or No? Plus News from GILD, Earnings from INTC & MAT Oct 22 / Zacks.com - Paid Partner Content |
| Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus Oct 23 / Zacks.com - Paid Partner Content | Biotech Stock Roundup: BIIB Posts Q3 Results, VRTX Stops Study & Other Updates Oct 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 60.67 |
| Today’s open | 63.38 |
| Day’s range | 60.50 - 63.63 |
| Volume | 1,621,345 |
| Average volume (3 months) | 9,047,386 |
| Market cap | $76.2B |
Data as of 7:57pm ET, 10/23/2020
Growth & Valuation
| Earnings growth (last year) | +0.91% |
| Earnings growth (this year) | +3.40% |
| Earnings growth (next 5 years) | -0.70% |
| Revenue growth (last year) | +0.49% |
| P/E ratio | NM |
| Price/Sales | 3.72 |
| Price/Book | 3.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | -2.44 | -0.75% |
| BIIBBiogen | -1.73 | -0.65% |
| MRNAModerna Inc | -0.32 | -0.45% |
| IMMUImmunomedics Inc | 0.00 | 0.00% |
Data as of 5:58pm ET, 10/23/2020
Financials
| Next reporting date | October 29, 2020 |
| EPS forecast (this quarter) | $1.90 |
| Annual revenue (last year) | $22.3B |
| Annual profit (last year) | $5.4B |
| Net profit margin | 24.13% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
